Mereo BioPharma Group plc - Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares (MREO)

94 filings reported holding MREO - Mereo BioPharma Group plc - Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares as of Q1 2024.
Mereo BioPharma Group plc - Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares (MREO) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 84M shares of 791M outstanding shares and own 10.62% of the company stock.
Largest 10 shareholders include Rubric Capital Management LP (13.6M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (9.33M shares), MANGROVE PARTNERS IM, LLC (8.75M shares), Rock Springs Capital Management LP (8.14M shares), 683 Capital Management, LLC (5.75M shares), JANUS HENDERSON GROUP PLC (5.12M shares), ALKEON CAPITAL MANAGEMENT LLC (4.24M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (3.65M shares), Clearline Capital LP (3.33M shares), and Soleus Capital Management, L.P. (2.62M shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.